ArticleJournal of racial and ethnic health disparities2026
L-SOLCO Pilot Study: Examining Allostatic Load and Cancer Treatment Disparities.
Article in Journal of racial and ethnic health disparities, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundCancer treatment disparities persist among low-income and underrepresented populations, with chronic stress and cumulative disadvantage increasingly linked to these disparities. Allostatic load, the physiological dysregulation due to repeated stress exposure—has been implicated in cancer incidence and outcomes, but its impact on treatment tolerance remains unclear. Because the first treatment for lung cancer is the most highly efficacious, the ability to withstand the first cancer treatment is the most critically important.
objectiveThe Longitudinal Study of Symptom Experience, Management Outcomes, and Adherence in Cancer (L-SOLCO) aims to explore how lifetime stress, perceived discrimination, and allostatic load contributes to disparities in lung cancer treatment tolerance and outcomes.
methodsThe study will enroll 30 patients with advanced-stage non-small cell lung cancer prior to, or during first treatment. Data will include patient surveys, biological markers, medical record abstraction, and qualitative interviews. This pilot study will establish feasibility and generate preliminary data regarding lifetime stress, social determinants of health and allostatic load and their contribution to cancer treatment disparities. Outcomes will include feasibility, participant engagement, retention, and baseline and longitudinal data on stress exposure, symptom burden, and chemotherapy dose modifications at 3- and 6- months post-enrollment. ANALYSIS: Quantitative data will be analyzed using descriptive, comparative and correlative analyses to assess feasibility and disparities in cancer outcomes. Thematic analysis of qualitative interviews will identify barriers to care. RESULTS AND SIGNIFICANCE: This pilot study will establish feasibility and generate preliminary data regarding measuring lifetime stress, social determinants of health and allostatic load and their contribution to cancer treatment disparities. Potentially, findings will inform interventions to improve treatment adherence and outcomes among highly stressed, disadvantaged populations.
conclusionL-SOLCO will enhance understanding of the interplay between stress, biological aging, and cancer care disparities, providing a foundation for large-scale studies and equitable treatment strategies. Potentially, findings will inform interventions to improve treatment adherence and outcomes among disadvantaged populations.
Indexed as
Identifiers
41912758What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.